NASDAQ:FLGT | Free Cash Flow | Fulgent Genetics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2014-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$7.1M$5.2M$1.9M
2025-12-31-$78.14M$4.98M-$83.12M
2025-03-31-$4.43M$4.72M-$9.15M
2024-12-31$25.02M$3.78M$21.24M
2024-03-31$7.27M$4.06M$3.21M
2023-12-31$14.93M$3.11M$11.83M
2023-03-31-$7.91M$2.03M-$9.94M
2022-12-31$33.21M$4.72M$28.49M
2022-03-31$188.41M$5.36M$183.05M118.88%
2021-12-31$77.09M$5.98M$71.1M68.15%
2021-03-31$233.18M$11.49M$221.69M110.46%
2020-12-31$134.26M$23.79M$110.46M66.42%
2020-03-31$1.37M$796,000.00$570,000.00
2019-12-31-$116,000.00$461,000.00-$577,000.00
2019-03-31$1.06M$134,000.00$921,000.00
2018-12-31$778,000.00$123,000.00$655,000.00
2018-03-31-$1.29M$1.12M-$2.41M
2017-12-31-$1.24M$1.14M-$2.38M
2017-03-31$1.51M$90,000.00$1.42M611.21%
2016-12-31$1.25M$409,000.00$845,000.00103.94%
2016-03-31$875,000.00$177,000.00$698,000.00
2015-12-31-$535,000.00$225,000.00-$760,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$101.64M$22.57M-$124.21M
2024-12-31$21.06M$40.32M-$19.26M
2023-12-31$27M$22.21M$4.8M
2022-12-31$253.52M$18.78M$234.75M163.70%
2021-12-31$538.58M$23.81M$514.77M101.46%
2020-12-31$140.63M$35.13M$105.5M49.23%
2019-12-31$5.52M$1.18M$4.34M
2018-12-31-$675,000.00$2.32M-$3M
2017-12-31$1.33M$2.9M-$1.56M
2016-12-31$4.41M$3.79M$617,000.00
2015-12-31-$969,000.00$2.1M-$3.07M
2014-12-31-$4.4M$731,000.00-$5.13M